Send us Feedback

Elan Corporation (ELN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ELN » Topics » j Current liabilities at 31 December:

This excerpt taken from the ELN 6-K filed Mar 30, 2009.
j Current liabilities at 31 December:
 
                 
    2008
 		    2007
 		 
    $m     $m  
 
 
Due to group undertakings
    1,326.7       1,370.0  
Accrued expenses
    0.5       0.5  
Finance lease obligation (net of finance charges)
    1.1       1.1  
                 
Current liabilities
    1,328.3       1,371.6  

     
Elan Corporation, plc 2008 Annual Report
  171

Table of Contents

 
 
As part of its normal operating activities, the parent company enters into transactions with other group undertakings. This includes the receipt of financing in the form of loans, in addition to trading activities such as the receipt of goods or services to group companies. Loans received from group undertakings are repayable on demand. As a result, no discounting is applied to these balances. In 2007, $1.2 billion was advanced from Elan Pharma International Limited, an indirect wholly owned subsidiary of the parent company, as a loan repayable on demand.
 
This excerpt taken from the ELN 6-K filed Mar 31, 2008.
m Current liabilities at 31 December:
 
                 
    2007
 		    2006
 		 
    $m     $m  
 
 
Due to group undertakings     1,370.0       197.0  
Accrued expenses
    0.5       0.8  
Finance lease obligation (net of finance charges)
    1.1       1.2  
                 
Current liabilities
    1,371.6       199.0  
                 
 
As part of our normal operating activities, we enter into transactions with other group undertakings. This includes the receipt of financing in the form of loans, in addition to trading activities such as the receipt of goods or services to group companies. Loans received from group undertakings are repayable on demand. As a result, no discounting is applied to these balances. In 2007, $1,200 million was advanced from Elan Pharma International Limited, a wholly owned subsidiary of the parent company, as a loan repayable on demand.
 

EXCERPTS ON THIS PAGE:

6-K
Mar 30, 2009
6-K
Mar 31, 2008

RELATED TOPICS for ELN:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki